RUFY3 and cancer: Among the six transcript variants of RUFY3 annotated on NCBI, only variant 2 (469 amino acids long) is functionally characterized and shown to regulate axon guidance in neurons and migration of cancer cells, processes that depend on actin cytoskeletal dynamics44–48.